Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
THE biotechnology industry's two-year run of riches is at risk after a decision by the biggest US drug manager to block one of the best-selling products in history.
Since the start of 2013, the Standard & Poor's Biotechnology Index has gained 134 per cent, almost...